CITY-OF-TAMPERE
17.9.2022 16:01:36 CEST | Business Wire | Press release
Sara Hildén Art Museum in Tampere Finland is proud to present Thomas Houseago’s first exhibition in the Nordic countries. Thomas Houseago is a world-renowned artist. In the Tampere exhibition, Houseago is presenting his own sculptures and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. Cave and Pitt are already renowned in their respective fields of music and cinema, but this is the first time ever they have exhibited their artwork pieces created during the course of an ongoing dialogue with Houseago.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005685/en/
Sara Hildén Art Museum in Tampere Finland presents Thomas Houseago’s first exhibition in the Nordic countries. Houseago is presenting his own sculpture and paintings alongside a ceramic series by Nick Cave and sculptures by Brad Pitt. The Exhibition opened on 17th September 2022. Museum Director Anna Hjorth-Röntynen, Nick Cave, Chief Curator Sarianne Saikkonen, Thomas Houseago, Mayor of Tampere Anna-Kaisa Ikonen and Brad Pitt. Photo: Jussi Koivunen
“I’m very happy and proud that Thomas Houseago decided to bring WE to Tampere. It is also exciting to get to experience a new and different artistic side of Nick Cave and Brad Pitt. WE delivers a strong message of working together, creating something new and a sense of community that is compatible with Tampere, as the city is known for its capacity for change and making bold decisions together. The message of doing together and relying on each other is very powerful in these turbulent times”, says Anna-Kaisa Ikonen, Mayor of Tampere.
In addition to the WE-exhibition at Sara Hildén, Tampere’s autumn and winter of art is plentiful and bright. Tampere Art Museum offers rarities from Finnish art foundations commencing on Oct 8th. The exhibition includes works by artists such as Helene Schjerfbeck, Ellen Thesleff, Fanny Churberg, Akseli Gallen-Kallela and Tyko Sallinen. The other museums of Tampere, for example Vapriikki, offer experiences for the whole family. Especially the Moomin Museum is a favourite of kids.
The Tampere Philharmonic plays beloved classics and new pieces. The brand new Nokia Arena will host exciting international concerts. Tampere is also the theatre capital of Finland, and the theatres of Tampere are full of great musicals, drama, comedy and crime stories.
Tampere has direct flight routes to many European destinations, for example to Amsterdam, Oslo, Malaga, Riga and München. It is also easily reached from the Finnish capital Helsinki, for example, the train ride from Helsinki to Tampere takes about 1,5 hours.
Thomas Houseago – WE with Nick Cave & Brad Pitt 18.9.2022 – 15.1.2023 at Sara Hildén Art Museum.
www.sarahildenintaidemuseo.fi, www.tampere.fi/en/international-tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005685/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release
–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom